As of 2026-03-17, the EV/EBITDA ratio of OPKO Health Inc (OPK) is -7.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPK's latest enterprise value is 883.27 mil USD. OPK's TTM EBITDA according to its financial statements is -126.17 mil USD. Dividing these 2 quantities gives us the above OPK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 10.4x | 9.0x |
| Forward P/E multiples | 7.4x - 12.7x | 9.2x |
| Fair Price | (1.21) - (1.70) | (1.49) |
| Upside | -201.4% - -242.8% | -224.9% |
| Date | EV/EBITDA |
| 2026-03-13 | -7.00 |
| 2026-03-12 | -6.82 |
| 2026-03-11 | -6.82 |
| 2026-03-10 | -7.00 |
| 2026-03-09 | -7.12 |
| 2026-03-06 | -6.94 |
| 2026-03-05 | -6.88 |
| 2026-03-04 | -7.06 |
| 2026-03-03 | -7.00 |
| 2026-03-02 | -7.30 |
| 2026-02-27 | -7.06 |
| 2026-02-26 | -7.06 |
| 2026-02-25 | -6.94 |
| 2026-02-24 | -6.76 |
| 2026-02-23 | -6.76 |
| 2026-02-20 | -7.06 |
| 2026-02-19 | -7.12 |
| 2026-02-18 | -7.18 |
| 2026-02-17 | -7.18 |
| 2026-02-13 | -7.24 |
| 2026-02-12 | -7.12 |
| 2026-02-11 | -7.36 |
| 2026-02-10 | -7.18 |
| 2026-02-09 | -7.18 |
| 2026-02-06 | -7.30 |
| 2026-02-05 | -7.24 |
| 2026-02-04 | -7.36 |
| 2026-02-03 | -7.42 |
| 2026-02-02 | -7.54 |
| 2026-01-30 | -7.42 |
| 2026-01-29 | -7.48 |
| 2026-01-28 | -7.54 |
| 2026-01-27 | -7.60 |
| 2026-01-26 | -7.66 |
| 2026-01-23 | -7.78 |
| 2026-01-22 | -8.02 |
| 2026-01-21 | -8.14 |
| 2026-01-20 | -7.60 |
| 2026-01-16 | -7.54 |
| 2026-01-15 | -7.54 |
| 2026-01-14 | -7.66 |
| 2026-01-13 | -7.90 |
| 2026-01-12 | -7.84 |
| 2026-01-09 | -8.02 |
| 2026-01-08 | -8.08 |
| 2026-01-07 | -8.02 |
| 2026-01-06 | -7.78 |
| 2026-01-05 | -7.54 |
| 2026-01-02 | -7.48 |
| 2025-12-31 | -7.42 |